Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| ALLIANCE FIB | AFOP | 16.09% |
| A M R CP | AAMRQ | 9.04% |
| JAZZ PHARMAC | JAZZ | 5.30% |
| DIXIE GROUP | DXYN | 5.59% |
| SANTARUS INC | SNTS | 4.53% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Intel Corporation ( INTC - Analyst Report ) is not fooling around when it mentions the tough economic environment. A few moments ago, the technology giant announced third-quarter revenue of $13.5 billion, which was above the company’s lowered guidance of $13.2 billion. However, that’s a very far cry from the original outlook of $13.8 billion to $14.8 billion. It was also down more than 5% from a year ago. The Zacks Consensus Estimate was at $13.17 billion.
The company lowered its guidance in early September citing a “weaker than expected demand in a challenging macroeconomic environment.” More specifically, the personal computer industry is in a major slump. As a result, Intel moved into the third quarter report with downward earnings estimate revisions. For example, in just the last 30 days, the company has witnessed 18 downward revisions out of 41 total estimates… with none to the upside.
The company is currently a Zacks #5 Rank (Strong Sell).
Earnings per share came in at 58 cents, which was ahead of the Zacks Consensus Estimate of 50 cents. However, beating quarterly expectations has never been a problem for Intel. The company has an impressive streak of outperformance stretching back years. Instead, it’s all about the guidance.
For the fourth quarter, Intel forecasts revenue of $13.6 billion, plus or minus $500 million. Therefore, the outlook is right around the Zacks Consensus Estimate of approximately $13.6 billion.
In and of itself, Intel is still the leader in its industry. The company said it is pleased with the progress in Ultrabooks and phones. It’s also excited about the range of Intel-based tablets coming out. However, the market is just not cooperating at the moment, which was even further underscored when main competitor Advanced Micro Devices recently warned.
We’ll have to wait and see how analysts will digest the new numbers, though Intel is unlikely to see a Zacks #3 Rank (Hold) or better for a while.
Stay tuned for a lot more detailed info on the quarter…
Read the full reports :
Analyst Report on INTC